Article Details

Synlogic awarded the FDA the Fast Track designation SYNB1353 for the treatment of ... - Bollyinside

Retrieved on: 2022-08-23 11:13:49

Tags for this article:

Click the tags to see associated articles and topics

Synlogic awarded the FDA the Fast Track designation SYNB1353 for the treatment of ... - Bollyinside. View article details on HISWAI: https://www.bollyinside.com/today/news/agency/synlogic-awarded-the-fda-the-fast-track-designation-synb1353-for-the-treatment-of-homocystinuria-hcu/

Excerpt

(Nasdaq: SYBX), a clinical biotechnology company developing drugs for metabolic and immune diseases through its own approach to synthetic biology, ...

Article found on: www.bollyinside.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up